Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1Phase 2 1

Status

Recruiting 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Thoracic 2Gynecologic 2Gastrointestinal 2Plasma cell 1Genitourinary 1

Conditions

Breast Neoplasms 4Inflammation 1Diarrhea 1Breast Carcinoma In Situ 1

Interventions

Paclitaxel 161Fulvestrant 155Trastuzumab 152pembrolizumab 144Letrozole 136Carboplatin 118pertuzumab 104Cyclophosphamide 102Capecitabine 102Specimen Handling 101Anastrozole 90palbociclib 85abemaciclib 81Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 73trastuzumab deruxtecan 69Radiotherapy 61Biopsy 59Surveys and Questionnaires 56Gemcitabine 52130-nm albumin-bound paclitaxel 52sacituzumab govitecan 50olaparib 50Standard of Care 49Blood Specimen Collection 49Taxes 47Doxorubicin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Probiotics × Breast × 1 year × Clear all
NCT07607548 2026-05-26

Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer

Poznan University of Medical Sciences

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Inflammation

NCT05562518 2026-04-30

GRACE

University Hospital, Ghent

Phase 4 Active not recruiting
160 enrolled
Breast

Breast Neoplasms

NCT06039644 2026-03-06

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

GenMont Biotech Incorporation

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT06892093 2025-09-08

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
308 enrolled
Breast

Breast Neoplasms, Diarrhea

NCT07044310 2025-07-29

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Mayo Clinic

Phase 2 Recruiting
38 enrolled
Breast

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡